Cargando…
Pharmacogenomics of EGFR-targeted therapies in non–small cell lung cancer: EGFR and beyond
Commonly observed aberrations in epidermal growth factor receptor (EGFR) signaling have led to the development of EGFR-targeted therapies for various cancers, including non–small cell lung cancer (NSCLC). EGFR mutations and overexpression have further been shown to modulate sensitivity to these EGFR...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593375/ https://www.ncbi.nlm.nih.gov/pubmed/25962919 http://dx.doi.org/10.1186/s40880-015-0007-9 |